{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T00:17:01Z","timestamp":1780100221003,"version":"3.54.0"},"reference-count":194,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[1989,8,1]],"date-time":"1989-08-01T00:00:00Z","timestamp":617932800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Toxicol Adverse Drug Exp"],"published-print":{"date-parts":[[1989,8]]},"DOI":"10.1007\/bf03259913","type":"journal-article","created":{"date-parts":[[2012,11,30]],"date-time":"2012-11-30T10:09:33Z","timestamp":1354270173000},"page":"272-294","source":"Crossref","is-referenced-by-count":18,"title":["Biochemical Relationships Between Reye\u2019s and Reye\u2019s-Like Metabolic and Toxicological Syndromes"],"prefix":"10.1007","volume":"4","author":[{"given":"John","family":"Osterloh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Combest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,11,27]]},"reference":[{"issue":"1","key":"BF03259913_CR1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1038\/clpt.1986.144","volume":"40","author":"FS Abbott","year":"1986","unstructured":"Abbott FS, Kassam J, Orr JM, Farrell K. The effect of aspirin on valproic acid metabolism. Clinical Pharmacology and Therapeutics 40(1): 94\u2013100, 1986","journal-title":"Clinical Pharmacology and Therapeutics"},{"key":"BF03259913_CR2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0009-9120(87)80090-5","volume":"20","author":"C Angelini","year":"1987","unstructured":"Angelini C, Trevisan C, Isaya G, Pegolo G, Vergani L. Clinical varieties of carnitine and carnitine palmitoyl transferase deficiency. Clinical Biochemistry 20: 1\u20137, 1987","journal-title":"Clinical Biochemistry"},{"key":"BF03259913_CR3","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1212\/WNL.30.2.160","volume":"30","author":"CF Ansevin","year":"1980","unstructured":"Ansevin CF. Reye syndrome: serum-induced alterations in brain mitochondrial function are blocked by fatty-acid-free albumin. Neurology 30: 160\u2013166, 1980","journal-title":"Neurology"},{"key":"BF03259913_CR4","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1126\/science.887930","volume":"197","author":"JR Aprille","year":"1977","unstructured":"Aprille JR. Reye\u2019s syndrome: patient serum alters mitochondrial function and morphology in vitro. Science 197: 908\u2013910, 1977","journal-title":"Science"},{"key":"BF03259913_CR5","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0003-9861(83)90602-1","volume":"223","author":"CM Becker","year":"1983","unstructured":"Becker CM, Harris RA. Influence of valproic acid on hepatic carbohydrate and lipid metabolism. Archives of Biochemistry and Biophysics 223: 381\u2013392, 1983","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"BF03259913_CR6","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/0006-2944(82)90017-5","volume":"27","author":"BJ Bergen","year":"1982","unstructured":"Bergen BJ, Stumpf DA, Haas R, Parks JK, Equren LA. A mechanism of toxicity of isovaleric acid in rat liver mitochondria. Biochemical Medicine 27: 154\u2013160, 1982","journal-title":"Biochemical Medicine"},{"key":"BF03259913_CR7","first-page":"2858","volume":"41","author":"LL Bieber","year":"1982","unstructured":"Bieber LL, Emaus R, Valkner K, Farrell S. Possible functions of short-chain and medium-chain carnitine acyltransferases. Federal Proceeding 41: 2858\u20132862, 1982","journal-title":"Federal Proceeding"},{"key":"BF03259913_CR8","doi-asserted-by":"crossref","first-page":"2891","DOI":"10.1016\/0006-2952(78)90205-8","volume":"27","author":"D Billington","year":"1978","unstructured":"Billington D, Osmundsen H, Sherrat HSA. Mechanism of the metabolic disturbances caused by hypoglycin and by pent-4-enoic acid: in vitro studies. Biochemical Pharmacology 27: 2891\u20132900, 1978","journal-title":"Biochemical Pharmacology"},{"key":"BF03259913_CR9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1042\/bst0070106","volume":"7","author":"D Billington","year":"1979","unstructured":"Billington D. Mechanism of the hypoglycemia caused by hypoglycin and pent-4-enoate. Biochemical Society Transactions 7: 106\u2013111, 1979","journal-title":"Biochemical Society Transactions"},{"key":"BF03259913_CR10","doi-asserted-by":"crossref","first-page":"7417","DOI":"10.1016\/S0021-9258(19)45796-7","volume":"246","author":"I Bjorkheim","year":"1971","unstructured":"Bjorkheim I, Hamberg M. Omega oxidation of fatty acids. Journal of Biological Chemistry 246: 7417\u20137420, 1971","journal-title":"Journal of Biological Chemistry"},{"key":"BF03259913_CR11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0006-291X(85)91014-9","volume":"132","author":"SM Bjorge","year":"1985","unstructured":"Bjorge SM, Baillie TA. Inhibition of medium-chain fatty acid \u03b2-oxidation in vitro by valproic acid and its unsaturated metabolite, 2-n-propyl-4-pentenoic acid. Biochemical and Biophysical Research Communications 132: 245\u2013252, 1985","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"BF03259913_CR12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/BF01377353","volume":"139","author":"H Bohles","year":"1982","unstructured":"Bohles H, Richter K, Wagner-Thiessen E, Schafer H. Decreased serum carnitine in valproate induced Reye syndrome. European Journal of Pediatrics 139: 185\u2013186, 1982","journal-title":"European Journal of Pediatrics"},{"key":"BF03259913_CR13","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1093\/ajcp\/56.5.558","volume":"56","author":"C Bourgeois","year":"1971","unstructured":"Bourgeois C, Olson L, Comer D, et al. Encephalopathy and fatty degeneration of the viscera: a clinico-pathologic analysis of 40 cases. American Journal of Clinical Pathology 56: 558\u2013571, 1971","journal-title":"American Journal of Clinical Pathology"},{"key":"BF03259913_CR14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0016-5085(19)32471-0","volume":"69","author":"KE Bove","year":"1975","unstructured":"Bove KE, McAdams AJ, Partin JC, Partin JS, Hug G, et al. The hepatic lesion in Reye\u2019s syndrome. Gastroenterology 69: 685\u2013697, 1975","journal-title":"Gastroenterology"},{"key":"BF03259913_CR15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/BF03047369","volume":"7","author":"NT Brandt","year":"1984","unstructured":"Brandt NT. Symptoms and signs in organic aciduria. Journal of Inherited Metabolic Disease 7 (Suppl. 1): 23\u201327, 1984","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"BF03259913_CR16","first-page":"506","volume-title":"Methods in enzymology Vol. 72","author":"J Bremer","year":"1981","unstructured":"Bremer J, Osmundsen H, Christiansen RZ, Borrebaek B. Clofibrate. In Lowenstein JM (Ed.) Methods in enzymology Vol. 72, pp. 506\u2013519, Academic Press, New York, 1981"},{"key":"BF03259913_CR17","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0031-6997(25)06873-5","volume":"21","author":"R Bressler","year":"1969","unstructured":"Bressler R, Corredor C, Brendel K. Hypoglycin and hypoglycin-like compounds. Pharmacological Reviews 21: 105, 1969","journal-title":"Pharmacological Reviews"},{"key":"BF03259913_CR18","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJM197604152941602","volume":"294","author":"T Brown","year":"1976","unstructured":"Brown T, Hug G, Lansky L, Bove K, Scheve A, et al. Transiently reduced activity of carbamyl phosphate synthetase and ornithine transcarbamylase in liver of children with Reye\u2019s syndrome. New England Journal of Medicine 294: 861\u2013867, 1976","journal-title":"New England Journal of Medicine"},{"key":"BF03259913_CR19","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1056\/NEJM198406213102503","volume":"310","author":"SW Brusilow","year":"1984","unstructured":"Brusilow SW, Danney M, Waber LJ, et al. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis. New England Journal of Medicine 310: 1630\u20131634, 1984","journal-title":"New England Journal of Medicine"},{"key":"BF03259913_CR20","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00313894","volume":"232","author":"R Campostrini","year":"1985","unstructured":"Campostrini R, Zaccara G, Rossi L, Paganini M, Dorigotti A, et al. Valproate-induced hyperammonemia in two epileptic identical twins. Journal of Neurology 232: 167\u2013168, 1985","journal-title":"Journal of Neurology"},{"key":"BF03259913_CR21","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1152\/jappl.1986.61.4.1275","volume":"61","author":"JI Carlin","year":"1986","unstructured":"Carlin JI, Reddan WG, Sanjak M, Hodach R. Carnitine metabolism during prolonged exercise and recovery in humans. Journal of Applied Physiology 61: 1275\u20131278, 1986","journal-title":"Journal of Applied Physiology"},{"key":"BF03259913_CR22","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1056\/NEJM198012113032403","volume":"303","author":"PR Chapoy","year":"1980","unstructured":"Chapoy PR, Angelini C, Brown WJ, et al. Systemic carnitine deficiency \u2014 a treatable inherited lipid storage disease presenting as Reye\u2019s syndrome. New England Journal of Medicine 303: 1389\u20131394, 1980","journal-title":"New England Journal of Medicine"},{"key":"BF03259913_CR23","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1203\/00006450-198507000-00007","volume":"19","author":"PM Coates","year":"1985","unstructured":"Coates PM, Hale DE, Stanley CA, Corkey BE, Cortner JA. Genetic deficiency of medium chain acyl co-enzyme A dehydrogenase: studies in cultured skin fibroblasts and peripheral mononuclear leukocytes. Pediatric Research 19: 671\u2013676, 1985","journal-title":"Pediatric Research"},{"key":"BF03259913_CR24","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1016\/S0140-6736(75)92553-2","volume":"1","author":"MS Cooperstock","year":"1975","unstructured":"Cooperstock MS, Tucker RP, Baublis JV. Possible pathogenic role in Reye\u2019s syndrome. Lancet 1: 1272\u20131274, 1975","journal-title":"Lancet"},{"key":"BF03259913_CR25","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000469385","volume":"34","author":"D Cotariu","year":"1985","unstructured":"Cotariu D, Evans S, Zaidman JL. Effect of sodium valproate on subcellular fraction enzymes in rat liver. Enzyme 34: 196\u2013200, 1985","journal-title":"Enzyme"},{"issue":"2","key":"BF03259913_CR26","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0006-291X(83)80205-8","volume":"115","author":"FX Coude","year":"1983","unstructured":"Coude FX, Grimber G, Pelet A, Benoit Y. Action of the anti-epileptic drug, valproic acid, on fatty acid oxidation in isolated rat hepatocytes. Biochemical and Biophysical Research Communications 115(2): 730\u2013736, 1983","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"BF03259913_CR27","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0022-3476(81)80489-1","volume":"99","author":"DL Coulter","year":"1981","unstructured":"Coulter DL, Allen RJ. Hyperammonemia with valproic acid therapy. Journal of Pediatrics 99: 317\u2013319, 1981","journal-title":"Journal of Pediatrics"},{"key":"BF03259913_CR28","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/S0140-6736(80)91773-0","volume":"1","author":"DL Coulter","year":"1980","unstructured":"Coulter DL, Allen RJ. Secondary hyperammonemia: a possible mechanism of valproate encephalopathy. Lancet 1: 1310, 1980","journal-title":"Lancet"},{"key":"BF03259913_CR29","first-page":"32","volume":"54","author":"JF Crocker","year":"1986","unstructured":"Crocker JF, Renton KW, Lee SH, Rozee KR, Digout SC, et al. Biochemical and morphological characteristics of a mouse model of Reye\u2019s syndrome induced by the interaction of influenza B virus and a chemical emulsifier. Laboratory Investigation 54: 32\u201340, 1986","journal-title":"Laboratory Investigation"},{"key":"BF03259913_CR30","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/S0140-6736(74)91351-8","volume":"2","author":"FS Crocker","year":"1974","unstructured":"Crocker FS, Rozee KR, Ozere RL, et al. Insecticide and viral interaction as a cause of fatty visceral changes and encephalopathy in the mouse. Lancet 2: 22\u201324, 1974","journal-title":"Lancet"},{"key":"BF03259913_CR31","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1126\/science.179146","volume":"192","author":"JFS Crocker","year":"1976","unstructured":"Crocker JFS, Ozere RL, Safe SH, Digout SC, Rozee KR. Lethal interaction of ubiquitous insecticide carriers with virus. Science 192: 1351, 1976","journal-title":"Science"},{"key":"BF03259913_CR32","first-page":"375","volume":"124","author":"JFS Crocker","year":"1981","unstructured":"Crocker JFS, Bagnell PC. Reye\u2019s syndrome: a clinical review. Canadian Medical Association Journal 124: 375\u2013382, 1981","journal-title":"Canadian Medical Association Journal"},{"key":"BF03259913_CR33","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1542\/peds.69.1.53","volume":"69","author":"GR DeLong","year":"1982","unstructured":"DeLong GR, Glick TH. Encephalopathy of Reye\u2019s syndrome: a review of pathogenic hypotheses. Pediatrics 69: 53\u201363, 1982","journal-title":"Pediatrics"},{"key":"BF03259913_CR34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/clinids\/7.1.31","volume":"7","author":"DR Deshmukh","year":"1985","unstructured":"Deshmukh DR. Animal modelsof Reye\u2019s syndrome. Reviews of Infectious Diseases 7: 31\u201340, 1985","journal-title":"Reviews of Infectious Diseases"},{"key":"BF03259913_CR35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1212\/WNL.37.3.379","volume":"37","author":"FE Dreifuss","year":"1987","unstructured":"Dreifuss FE, Santilli N, Langer DH, Sweeney KP, Moline BA, et al. Valproic acid hepatic fatalities: a retrospective review. Neurology 37: 379\u2013385, 1987","journal-title":"Neurology"},{"key":"BF03259913_CR36","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1212\/WNL.36.3.367","volume":"36","author":"M DeVisser","year":"1986","unstructured":"DeVisser M, Scholte HR, Schulgens RBH, et al. Riboflavin-responsive lipid storage myopathy and glutaric aciduria type II of early adult onset. Neurology 36: 367\u2013372, 1986","journal-title":"Neurology"},{"key":"BF03259913_CR37","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1212\/WNL.28.2.105","volume":"28","author":"DC DeVivo","year":"1978","unstructured":"DeVivo DC. Reye\u2019s syndrome: a metabolic response to an acute mitochondrial insult? Neurology 28: 105\u2013108, 1978","journal-title":"Neurology"},{"key":"BF03259913_CR38","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1212\/WNL.34.2.157","volume":"34","author":"S DiDonato","year":"1984","unstructured":"DiDonato S, Pelucchetti D, Rimoldi M, et al. Systemic carnitine deficiency: clinical, biochemical, and morphological cure with L-carnitine. Neurology 34: 157\u2013162, 1984","journal-title":"Neurology"},{"key":"BF03259913_CR39","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1212\/WNL.36.7.957","volume":"36","author":"S DiDonato","year":"1986","unstructured":"DiDonato S, Frerman FE, Rimoldi M, Rinaldo P, Taroni F, et al. Systemic carnitine deficiency due to lack of electron transfer flavoprotein: ubiquinone oxidoreductase. Neurology 36: 957\u2013963, 1986","journal-title":"Neurology"},{"key":"BF03259913_CR40","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1056\/NEJM198212093072405","volume":"307","author":"AM DiGeorge","year":"1982","unstructured":"DiGeorge AM, Rezvani I, Garibaldi LR, Schwartz M. Prospective study of Maple-syrup urine disease for the first four days of life. New England Journal of Medicine 307: 1492\u20131495, 1982","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"BF03259913_CR41","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/BF03047373","volume":"7","author":"P Divry","year":"1984","unstructured":"Divry P, Vianey-Liaud C, Cotte J. Gas chromatography-mass spectrometry (GC-MS): Diagnosis of two cases of medium chain acyl CoA dehydrogenase deficiency. Journal of Inherited Metabolic Disease 7 (Suppl. 1): 44\u201347, 1984","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"BF03259913_CR42","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/BF03047374","volume":"7","author":"M Duran","year":"1984","unstructured":"Duran M, DeKlerk JBC, Wadman SK, Bruinvis L, Ketting D. The differential diagnosis of dicarboxylaciduria. Journal of Inherited Metabolic Disease 7: 48\u201351, 1984","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"BF03259913_CR43","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1126\/science.179.4076.899","volume":"179","author":"AG Engel","year":"1973","unstructured":"Engel AG, Angelini C. Carnitine deficiency of human skeletal muscle with associated lipid storage myopathy: a new syndrome. Science 179: 899\u2013902, 1973","journal-title":"Science"},{"issue":"1","key":"BF03259913_CR44","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1007\/BF03047372","volume":"7","author":"AG Engel","year":"1984","unstructured":"Engel AG, Rebouche CJ. Carnitine metabolism and inborn errors. Journal of Inherited Metabolic Disease 7 (Suppl. 1): 38\u201343, 1984","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"BF03259913_CR45","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1007\/BF00442488","volume":"147","author":"BO Eriksson","year":"1988","unstructured":"Eriksson BO, Lindstedt S, Nordin I. Hereditary defect in carnitine membrane transport is expressed in skin fibroblasts. European Journal of Pediatrics 147: 662\u2013663, 1988","journal-title":"European Journal of Pediatrics"},{"key":"BF03259913_CR46","first-page":"125","volume":"13","author":"PC Feng","year":"1958","unstructured":"Feng PC, Patrick SJ. Studies of the action of hypoglycin A, a hypoglycemic substance. British Journal of Pharmacology 13: 125\u2013130, 1958","journal-title":"British Journal of Pharmacology"},{"key":"BF03259913_CR47","first-page":"313","volume":"3","author":"JD Gaskins","year":"1984","unstructured":"Gaskins JD, Holt RJ, Postelnick M. Nondosage-dependent valproic acid-induced hyperammonemia and coma. Clinical Pharmacy 3: 313\u2013316, 1984","journal-title":"Clinical Pharmacy"},{"issue":"1","key":"BF03259913_CR48","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/BF03047376","volume":"7","author":"DC Gautheron","year":"1984","unstructured":"Gautheron DC. Mitochondrial oxidative phosphorylation and respiratory chain: Review. Journal of Inherited Metabolic Disease 7 (Suppl. 1): 57\u201361, 1984","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"BF03259913_CR49","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0022-3476(79)80110-9","volume":"95","author":"N Gerber","year":"1979","unstructured":"Gerber N, Dickinson RG, Harland RC, et al. Reye-like syndrome associated with valproic acid therapy. Journal of Pediatrics 95: 142\u2013144, 1979","journal-title":"Journal of Pediatrics"},{"key":"BF03259913_CR50","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1001\/archpedi.1972.02110180029003","volume":"124","author":"AM Glasgow","year":"1972","unstructured":"Glasgow AM, Cotton RB, Dhiensiri K, Kaen K. Reye\u2019s syndrome. I. Blood ammonia and consideration of the nonhistologic diagnosis. American Journal of Diseases of Children 124: 827\u2013833, 1972","journal-title":"I. Blood ammonia and consideration of the nonhistologic diagnosis. American Journal of Diseases of Children"},{"key":"BF03259913_CR51","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/0006-2952(83)90510-5","volume":"32","author":"AM Glasgow","year":"1983","unstructured":"Glasgow AM. Hypoglycin toxicity: studies of ammonia metabolism. Biochemical Pharmacology 32: 746\u2013748, 1983","journal-title":"Biochemical Pharmacology"},{"key":"BF03259913_CR52","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1203\/00006450-197503000-00005","volume":"9","author":"AM Glasgow","year":"1975","unstructured":"Glasgow AM, Chase HP. Production of the features of Reye\u2019s syndrome in rats with 4-pentenoic acid. Pediatric Research 9: 133\u2013139, 1975","journal-title":"Pediatric Research"},{"key":"BF03259913_CR53","first-page":"42","volume":"34","author":"JF Glasgow","year":"1985","unstructured":"Glasgow JF, Hicks EM, Jenkins JG, Keilty SR, Black GW, et al. Reye\u2019s syndrome. British Journal of Hospital Medicine 34: 42\u201345, 1985","journal-title":"British Journal of Hospital Medicine"},{"key":"BF03259913_CR54","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0005-2760(84)90300-X","volume":"794","author":"KD Golden","year":"1984","unstructured":"Golden KD, Kean AE. The biogenesis of dicarboxylic acids in rats given hypoglycin. Biochimica et Biophysica Acta 794: 83\u201388, 1984","journal-title":"Biochimica et Biophysica Acta"},{"issue":"1","key":"BF03259913_CR55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/BF03047371","volume":"7","author":"SI Goodman","year":"1984","unstructured":"Goodman SI, Frerman FE. Glutaric acidemia Type II (Multiple Acyl-CoA Dehydrogenation Deficiency). Journal of Inherited Metabolic Disease 7 (Suppl. 1): 33\u201337, 1984","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"BF03259913_CR56","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0006-2944(84)90064-4","volume":"31","author":"SI Goodman","year":"1984","unstructured":"Goodman SI, Valle D. Defective amino acid metabolism in hypoglycin treated rats. Biochemical Medicine 31: 97\u2013103, 1984","journal-title":"Biochemical Medicine"},{"key":"BF03259913_CR57","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1212\/WNL.37.8.1392","volume":"37","author":"KJ Goulden","year":"1987","unstructured":"Goulden KJ, Dooley JM, Camfield PR, Fraser AD. Clinical valproate toxicity induced by acetylsalicylic acid. Neurology 37: 1392\u20131394, 1987","journal-title":"Neurology"},{"key":"BF03259913_CR58","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.1600-0404.1983.tb01537.x","volume":"97","author":"L Gram","year":"1983","unstructured":"Gram L, Bentsen KD. Hepatic toxicity of antiepileptic drugs: a review. Acta Neurologica Scandinavica 97: 81\u201390, 1983","journal-title":"Acta Neurologica Scandinavica"},{"key":"BF03259913_CR59","first-page":"1152","volume":"4","author":"GR Granneman","year":"1984","unstructured":"Granneman GR, Wang S, Kesterson JW, Machinist JM. The hepatotoxicity of valproic acid and its metabolites in rats. II. Intermediary and valproic acid metabolism. Hepatology 4: 1152\u20131158, 1984","journal-title":"II. Intermediary and valproic acid metabolism. Hepatology"},{"key":"BF03259913_CR60","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0022-3476(88)80551-1","volume":"113","author":"C Greene","year":"1988","unstructured":"Greene C, Blitzer MG, Shapiro E. Inborn errors of metabolism and Reye\u2019s syndrome: differential diagnosis. Journal of Pediatrics 113: 156\u2013159, 1988","journal-title":"Journal of Pediatrics"},{"issue":"1","key":"BF03259913_CR61","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/BF03047370","volume":"7","author":"N Gregersen","year":"1984","unstructured":"Gregersen N. Fatty acyl-CoA dehydrogenase deficiency: enzyme measurement and studies on alternative metabolism. Journal of Inherited Metabolic Disease 7 (Suppl. 1): 28\u201332, 1984","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"BF03259913_CR62","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1203\/00006450-198210000-00012","volume":"16","author":"N Gregersen","year":"1982","unstructured":"Gregersen N, Wintzensen H, Kolvraa S, Christensen E, Christensen MF, et al. C6 -C10 dicarboxylic aciduria: investigations of a patient with riboflavin responsive multiple acyl CoA dehydrogenation defects. Pediatric Research 16: 861\u2013868, 1982","journal-title":"Pediatric Research"},{"key":"BF03259913_CR63","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/clinchem\/33.4.473","volume":"33","author":"J Greter","year":"1987","unstructured":"Greter J, Jacobson CE. Urinary organic acids: isolation and quantitation for routine metabolic screening. Clinical Chemistry 33: 473\u2013480, 1987","journal-title":"Clinical Chemistry"},{"key":"BF03259913_CR64","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1203\/00006450-198507000-00006","volume":"19","author":"DE Hale","year":"1985","unstructured":"Hale DE, Batshaw MT, Coates PM, Frerman FE, Goodman SI, et al. Long-chain acyl coenzyme A dehydrogenase deficiency: an inherited cause of nonketotic hypoglycemia. Pediatric Research 19: 666\u2013671, 1985","journal-title":"Pediatric Research"},{"key":"BF03259913_CR65","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1542\/peds.76.2.202","volume":"76","author":"JR Hansen","year":"1985","unstructured":"Hansen JR, McCray PB, Bale JF, Corbett AJ, Flanders DJ. Reye\u2019s syndrome associated with aspirin therapy for systemic lupus erythematosus. Pediatrics 76: 202\u2013205, 1985","journal-title":"Pediatrics"},{"key":"BF03259913_CR66","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1212\/WNL.31.11.1473","volume":"31","author":"R Haas","year":"1981","unstructured":"Haas R, Chir B, Stumpf DA, Parks JK, Eguren L. Inhibitory effects of sodium valproate on oxidative phosphorylation. Neurology 31: 1473\u20131476, 1981","journal-title":"Neurology"},{"key":"BF03259913_CR67","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/00007691-198612000-00004","volume":"8","author":"D Haidukewych","year":"1986","unstructured":"Haidukewych D, John G. Chronic valproic acid and coantiepileptic drug therapy and incidence of increases in serum liver enzymes. Therapeutic Drug Monitoring 8: 407\u2013410, 1986","journal-title":"Therapeutic Drug Monitoring"},{"key":"BF03259913_CR68","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00007691-198507030-00009","volume":"7","author":"D Haidukewych","year":"1985","unstructured":"Haidukewych D, John G, Zielinski J, Rodin EA. Chronic valproic acid therapy and the incidence of increases in plasma ammonia. Therapeutic Drug Monitoring 7: 290\u2013294, 1985","journal-title":"Therapeutic Drug Monitoring"},{"key":"BF03259913_CR69","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1542\/peds.76.2.202","volume":"76","author":"JR Hansen","year":"1985","unstructured":"Hansen JR, McCray PB, Bale JF, Corbett AJ, Flanders DJ. Reye\u2019s syndrome associated with aspirin therapy for systemic lupus erythematosus. Pediatrics 76: 202\u2013205, 1985","journal-title":"Pediatrics"},{"key":"BF03259913_CR70","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S0022-3476(87)80401-8","volume":"110","author":"JP Harpey","year":"1987","unstructured":"Harpey JP, Charpentier C, Coude M, Divry P, Paturneau-Jouas M. Sudden infant death syndrome and multiple acyl-coenzyme A dehydrogenase deficiency, ethylmalonic-adipic aciduria or systemic carnitine deficiency. Journal of Pediatrics 110: 881\u2013884, 1987","journal-title":"Journal of Pediatrics"},{"key":"BF03259913_CR71","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1212\/WNL.36.3.351","volume":"36","author":"K Hayasaka","year":"1986","unstructured":"Hayasaka K, Takahashi I, Kobayashi Y, Iinuma K, Narisawa K. Effects of valproate on biogenesis and function of liver mitochondria. Neurology 36: 351\u2013356, 1986","journal-title":"Neurology"},{"key":"BF03259913_CR72","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/ana.410030305","volume":"3","author":"MW Haymond","year":"1978","unstructured":"Haymond MW, Karl IE, Keating JP, DeVivo DC. Metabolic response to hypertonic glucose administration in Reye\u2019s syndrome. Annals of Neurology 3: 207\u2013215, 1978","journal-title":"Annals of Neurology"},{"key":"BF03259913_CR73","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/hep.1840070130","volume":"7","author":"JE Heubi","year":"1987","unstructured":"Heubi JE, Partin JC, Partin JS, Schubert WK. Reye\u2019s syndrome: current concepts. Hepatology 7: 155\u2013164, 1987","journal-title":"Hepatology"},{"key":"BF03259913_CR74","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1042\/bj1360173","volume":"136","author":"PC Holland","year":"1973","unstructured":"Holland PC, Senior AE, Sherratt HSA. Biochemical effects of the hypoglycemic compound pent-4-enoic acid and related non-hypoglycemic fatty acids. Biochemical Journal 136: 173\u2013184, 1973","journal-title":"Biochemical Journal"},{"key":"BF03259913_CR75","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/0006-2952(85)90670-7","volume":"34","author":"S Horie","year":"1985","unstructured":"Horie S, Suga T. Enhancement of peroxisomal \u03b2-oxidation in the liver of rats and mice treated with valproic acid. Biochemical Pharmacology 34: 1357\u20131362, 1985","journal-title":"Biochemical Pharmacology"},{"key":"BF03259913_CR76","doi-asserted-by":"crossref","first-page":"3178","DOI":"10.1001\/jama.1988.03410210090045","volume":"260","author":"ES Hurwitz","year":"1988","unstructured":"Hurwitz ES. The changing epidemiology of Reye\u2019s syndrome in the United States: further evidence for a Public Health success. Journal of the American Medical Association 260: 3178\u20133180, 1988","journal-title":"Journal of the American Medical Association"},{"key":"BF03259913_CR77","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1001\/jama.1987.03390140075030","volume":"257","author":"ES Hurwitz","year":"1987","unstructured":"Hurwitz ES, Barrett MJ, Bregman D, et al. Public health service study of Reye\u2019s syndrome and medications. Journal of the American Medical Association 257: 1905\u20131911, 1987","journal-title":"Journal of the American Medical Association"},{"key":"BF03259913_CR78","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0046-8177(77)80006-3","volume":"8","author":"TC Iancu","year":"1977","unstructured":"Iancu TC, Mason WH, Neustein HB. Ultrastructural abnormalities of liver cells in Reye\u2019s syndrome. Human Pathology 8: 421\u2013431, 1977","journal-title":"Human Pathology"},{"key":"BF03259913_CR79","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1093\/ajcp\/66.3.570","volume":"66","author":"T Iancu","year":"1976","unstructured":"Iancu T, Elian E. Ultrastructural changes in aspirin hepatotoxicity. American Journal of Clinical Pathology 66: 570\u2013575, 1976","journal-title":"American Journal of Clinical Pathology"},{"key":"BF03259913_CR80","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/clinchem\/31.11.1795","volume":"31","author":"RA Iles","year":"1985","unstructured":"Iles RA, Hind AJ, Chalmers RA. Use of proton nuclear magnetic resonance spectroscopy in detection and study of organic acidurias. Clinical Chemistry 31: 1795\u20131801, 1985","journal-title":"Clinical Chemistry"},{"key":"BF03259913_CR81","first-page":"875","volume":"77","author":"S Itoh","year":"1982","unstructured":"Itoh S, Yamaba Y, Matsuo S, Saka M, Ichinoe A. Sodium valproate-induced liver injury. American Journal of Gastroenterology 77: 875\u2013879, 1982","journal-title":"American Journal of Gastroenterology"},{"key":"BF03259913_CR82","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0021-9258(18)33067-9","volume":"258","author":"RH Jackson","year":"1983","unstructured":"Jackson RH, Singer TP. Inactivation of the 2-ketoglutarate and pyruvate dehydrogenase complexes of beef heart by branched chain ketoacids. Journal of Biological Chemistry 258: 1857\u20131865, 1983","journal-title":"Journal of Biological Chemistry"},{"key":"BF03259913_CR83","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/bmj.294.6568.337","volume":"295","author":"JG Jenkins","year":"1987","unstructured":"Jenkins JG, Glasgow JFT, Black GW, et al. Reye\u2019s syndrome-assessment of intracranial monitoring. British Medical Journal 295: 337\u2013338, 1987","journal-title":"British Medical Journal"},{"key":"BF03259913_CR84","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/hep.1840040611","volume":"4","author":"AM Jezequel","year":"1984","unstructured":"Jezequel AM, Bonazzi P, Novelli G, Venturini C, Orlandi F. Early structural and function changes in liver of rats treated with a single dose of valproic acid. Hepatology 4: 1159\u20131166, 1984","journal-title":"Hepatology"},{"key":"BF03259913_CR85","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S0168-8278(85)80744-3","volume":"1","author":"M Jimenez-Rodriguezvila","year":"1985","unstructured":"Jimenez-Rodriguezvila M, Caro-Paton A, Duenas-Laita A, Conde M, Coca MC, et al. Histological, ultrastructural and mitochondrial oxidative phosphorylation studies in liver of rats chronically treated with oral valproic acid. Journal of Hepatology 1: 453\u2013465, 1985","journal-title":"Journal of Hepatology"},{"key":"BF03259913_CR86","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1042\/cs0630455","volume":"63","author":"ES Kang","year":"1982","unstructured":"Kang ES, Capaci MT, Korones DN, Tekade N. Liver coenzyme A ester content: comparison between Reye\u2019s syndrome and control subjects. Clinical Science 63: 455\u2013460, 1982","journal-title":"Clinical Science"},{"key":"BF03259913_CR87","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/0885-4505(86)90094-0","volume":"35","author":"ES Kang","year":"1986","unstructured":"Kang ES, Capaci MT, Sawhney B, Greenshaw J. Total and perixosomal fatty acid oxidation by liver homogenates from autopsied Reye\u2019s and control subjects. Biochemical Medicine and Metabolic Biology 35: 361\u2013366, 1986","journal-title":"Biochemical Medicine and Metabolic Biology"},{"key":"BF03259913_CR88","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/clinchem\/29.6.1012","volume":"29","author":"ES Kang","year":"1983","unstructured":"Kang ES, Todd TA, Capaci MT, Schwenzer K, Jabbour JT. Measurement of true salicylate concentrations in serum from patients with Reye\u2019s syndrome. Clinical Chemistry 29: 1012\u20131014, 1983","journal-title":"Clinical Chemistry"},{"key":"BF03259913_CR89","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1212\/WNL.25.1.16","volume":"25","author":"G Karpati","year":"1975","unstructured":"Karpati G, Carpenter S, Engel AG, et al. The syndrome of systemic carnitine deficiency: clinical, morphologic, biochemical and pathophysiologic features. Neurology 25: 16\u201324, 1975","journal-title":"Neurology"},{"key":"BF03259913_CR90","first-page":"1283","volume":"2","author":"JDS Kay","year":"1986","unstructured":"Kay JDS, Hilton-Jones D, Hyman N. Valproate toxicity and ornithine carbamoyltransferase deficiency. Lancet 2: 1283\u20131284, 1986","journal-title":"Lancet"},{"key":"BF03259913_CR91","first-page":"206","volume":"24","author":"EA Kean","year":"1975","unstructured":"Kean EA, Walters P. Counteraction of glucocorticoid-induced hyperglycemia by hypoglycin. West Indian Medical Journal 24: 206, 1975","journal-title":"West Indian Medical Journal"},{"key":"BF03259913_CR92","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1017\/S0317167100044358","volume":"9","author":"DL Keene","year":"1982","unstructured":"Keene DL, Humphreys P, Carpenter B, Fletcher JP. Valproic acid producing a Reye\u2019s-like syndrome. Canadian Journal of Neurological Sciences 9: 435\u2013437, 1982","journal-title":"Canadian Journal of Neurological Sciences"},{"key":"BF03259913_CR93","first-page":"1143","volume":"4","author":"JW Kesterson","year":"1984","unstructured":"Kesterson JW, Granneman GR, Machinist JM. The hepatotoxicity of valproic acid and its metabolites in rats. I. Toxicologic, biochemical and histopathologic studies. Hepatology 4: 1143\u20131152, 1984","journal-title":"I. Toxicologic, biochemical and histopathologic studies. Hepatology"},{"key":"BF03259913_CR94","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1097\/00005176-198701000-00026","volume":"6","author":"A Kimura","year":"1987","unstructured":"Kimura A, Yoshida I, Yamashita F. Necessity of liver biopsy for accurate diagnosis of Reye\u2019s syndrome. Journal of Pediatric Gastroenterology and Nutrition 6: 153\u2013154, 1987","journal-title":"Journal of Pediatric Gastroenterology and Nutrition"},{"key":"BF03259913_CR95","first-page":"377","volume-title":"Progress in liver diseases, Vol. 7","author":"A Kirn","year":"1982","unstructured":"Kirn A, Gut J, Gendroult J. Interaction of viruses with sinusoidal cells. In Popper & Schoffer (Eds). Progress in liver diseases, Vol. 7, pp. 377\u2013392, Grune and Stratton Inc., Orlando, 1982"},{"key":"BF03259913_CR96","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(86)91947-1","volume":"2","author":"JW Larrick","year":"1986","unstructured":"Larrick JW, Kunkel SL. Is Reye\u2019s syndrome caused by augmented release of tumour necrosis factor? Lancet 2: 132\u2013133, 1986","journal-title":"Lancet"},{"key":"BF03259913_CR97","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1002\/hep.1840040308","volume":"4","author":"PS Latham","year":"1984","unstructured":"Latham PS, LaBrecque DR, McReynolds JW, Klatskin G. Liver ultrastructure in mitochondrial urea cycle enzyme deficiencies and comparison with Reye\u2019s syndrome. Hepatology 4: 404\u2013407, 1984","journal-title":"Hepatology"},{"key":"BF03259913_CR98","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/j.1528-1157.1986.tb03584.x","volume":"27","author":"MC Laub","year":"1986","unstructured":"Laub MC, Paetzke-Brunner I, Jaeger G. Serum carnitine during valproic acid therapy. Epilepsia 27: 559\u2013562, 1986","journal-title":"Epilepsia"},{"key":"BF03259913_CR99","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0021-9258(17)34897-4","volume":"253","author":"PB Lazarow","year":"1978","unstructured":"Lazarow PB. Rat liver peroxisomes catalyze the \u03b2-oxidation of fatty acids. Journal of Biological Chemistry 253: 1522\u20131528, 1978","journal-title":"Journal of Biological Chemistry"},{"key":"BF03259913_CR100","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJM198410183111604","volume":"311","author":"FD Ledley","year":"1984","unstructured":"Ledley FD, Levy HL, Shih VE, Benjamin R, Mahoney MJ. Benign methylmalonic aciduria. New England Journal of Medicine 311: 1015\u20131018, 1984","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"BF03259913_CR101","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF03047367","volume":"7","author":"JV Leonard","year":"1984","unstructured":"Leonard JV, Daish P, Naughten ER, Bartlett K. The management and long term outcome of organic acidemias. Journal of Inherited Metabolic Disease 7 (Suppl. 1): 13\u201317, 1984","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"BF03259913_CR102","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/hep.1840020622","volume":"2","author":"JH Lewis","year":"1982","unstructured":"Lewis JH, Zimmerman HJ, Garrett CT, Rosenberg E. Valproate-induced hepatic steatogenesis in rats. Hepatology 2: 870\u2013873, 1982","journal-title":"Hepatology"},{"key":"BF03259913_CR103","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1203\/00006450-197901000-00010","volume":"13","author":"CC Linneman","year":"1979","unstructured":"Linneman CC, Ueda K, Hug G, Schaffer A, Clark A, et al. Salicylate intoxication and influenza in ferrets. Pediatric Research 13: 44.47, 1979","journal-title":"Pediatric Research"},{"key":"BF03259913_CR104","first-page":"36","volume":"128","author":"FH Lovejoy","year":"1974","unstructured":"Lovejoy FH, Smith AL, Bresnan MJ, Wood JN, Victor DI, et al. Clinical staging in Reye\u2019s syndrome. American Journal of Diseases of Children 128: 36\u201341, 1974","journal-title":"American Journal of Diseases of Children"},{"key":"BF03259913_CR105","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1203\/00006450-197404000-00576","volume":"8","author":"P Mamunes","year":"1974","unstructured":"Mamunes P, DeVries GH, Miller CD, David RB. Fatty acids in Reye\u2019s syndrome. Pediatric Research 8: 436, 1974","journal-title":"Pediatric Research"},{"key":"BF03259913_CR106","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1172\/JCI109619","volume":"64","author":"S Mantagos","year":"1979","unstructured":"Mantagos S, Genel M, Tanaka K. Ethylmalonic adipic aciduria: In vivo and in vitro studies indicating deficiency of activities of multiple acyl CoA dehydrogenases. Journal of Clinical Investigations 64: 1580\u20131589, 1979","journal-title":"Journal of Clinical Investigations"},{"key":"BF03259913_CR107","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0003-9861(86)90646-6","volume":"244","author":"ME Martens","year":"1986","unstructured":"Martens ME, Chang CH, Lee CP. Reye\u2019s syndrome: mitochondrial swelling and Ca2+ release induced by Reye\u2019s plasma, allantoin, and salicylate. Archives of Biochemistry and Biophysics 244: 773\u2013786, 1986","journal-title":"Archives of Biochemistry and Biophysics"},{"key":"BF03259913_CR108","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1056\/NEJM198304143081501","volume":"308","author":"SM Matsui","year":"1983","unstructured":"Matsui SM, Maurice MJ, Rosenberg LE. The natural history of the inherited methylmalonic acidemias. New England Journal of Medicine 308: 857\u2013861, 1983","journal-title":"New England Journal of Medicine"},{"key":"BF03259913_CR109","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1016\/0006-2952(86)90181-4","volume":"35","author":"R Mentlein","year":"1986","unstructured":"Mentlein R, Lembke B, Vik H, Berge RK. Different introduction of microsomal carboxylesterases, palmitoyl-CoA hydrolase and acyl L-carnitine hydrolase in rat liver after treatment with clofibrate. Biochemical Pharmacology 35: 2727\u20132730, 1986","journal-title":"Biochemical Pharmacology"},{"key":"BF03259913_CR110","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1001\/archinte.1987.00370010065016","volume":"147","author":"JM Meyhaler","year":"1987","unstructured":"Meyhaler JM, Varma RR. Reye\u2019s syndrome in adults: diagnostic considerations. Archives of Internal Medicine 147: 61\u201364, 1987","journal-title":"Archives of Internal Medicine"},{"key":"BF03259913_CR111","first-page":"673","volume":"13","author":"RDG Milner","year":"1977","unstructured":"Milner RDG, Wirdnam PK. Hypoglycin stimulates insulin secretion. Diabetologia 13: 673, 1977","journal-title":"Diabetologia"},{"key":"BF03259913_CR112","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1203\/00006450-198011000-00013","volume":"14","author":"RA Mitchell","year":"1980","unstructured":"Mitchell RA, Ram ML, Arcinue EL, Chang CH. Comparison of cytosolic and mitochondrial hepatic enzyme alterations in Reye\u2019s syndrome. Pediatric Research 14: 1216\u20131221, 1980","journal-title":"Pediatric Research"},{"key":"BF03259913_CR113","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1007\/BF02534931","volume":"21","author":"MG Murphy","year":"1986","unstructured":"Murphy MG, Archambault-Schertzer L, Ackman RG, Crocker JF. Serum lipid abnormalities in a chemical\/viral mouse model for Reye\u2019s syndrome. Lipids 21: 378\u2013382, 1986","journal-title":"Lipids"},{"key":"BF03259913_CR114","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/S0140-6736(85)91481-3","volume":"1","author":"JV Murphy","year":"1985","unstructured":"Murphy JV, Marquardt KM, Shug AL. Valproic acid associated abnormalities of carnitine metabolism. Lancet 1: 820\u2013821, 1985","journal-title":"Lancet"},{"key":"BF03259913_CR115","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF02312518","volume":"3","author":"EW Naylor","year":"1980","unstructured":"Naylor EW, Mosovitch LL, Guthrie R, Evans JE, Tieckelman H. Intermittent dicarboxylic aciduria in two siblings with non-ketogenic hypoglycemia: an apparent defect in \u03b2-oxidation of fatty acids. Journal of Inherited Metabolic Disease 3: 19\u201324, 1980","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"BF03259913_CR116","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1542\/peds.66.6.865","volume":"66","author":"DB Nelson","year":"1980","unstructured":"Nelson DB, Kimbrough R, Landrigan PS, et al. Aflatoxin and Reye\u2019s syndrome: a case control study. Pediatrics 66: 865\u2013869, 1980","journal-title":"Pediatrics"},{"key":"BF03259913_CR117","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1056\/NEJM198811173192008","volume":"319","author":"WL Nyhan","year":"1988","unstructured":"Nyhan WL. Abnormalities of fatty acid oxidation. New England Journal of Medicine 319: 1344\u20131346, 1988","journal-title":"New England Journal of Medicine"},{"key":"BF03259913_CR118","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1073\/pnas.79.3.908","volume":"79","author":"PJ Ogburn","year":"1982","unstructured":"Ogburn PJ, Sharp H, Lloyd-Still JD, Johnson SB, Holman RT. Abnormal polyunsaturated fatty acid patterns of serum lipids in Reyes syndrome. Proceedings of the National Academy of Sciences (USA) 79: 908\u2013911, 1982","journal-title":"Proceedings of the National Academy of Sciences (USA)"},{"key":"BF03259913_CR119","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/00007611-197605000-00045","volume":"69","author":"PL Ogburn","year":"1976","unstructured":"Ogburn PL. Medium and long chain serum free fatty acids in a case of Reye\u2019s syndrome. Southern Medical Journal 69: 632\u2013633, 1976","journal-title":"Southern Medical Journal"},{"key":"BF03259913_CR120","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S0022-3476(82)80320-X","volume":"101","author":"Y Ohtani","year":"1982","unstructured":"Ohtani Y, Endo F, Matsuda I. Carnitine deficiency and hyperammonemia associated with valproic acid therapy. Journal of Pediatrics 101: 782\u2013785, 1982","journal-title":"Journal of Pediatrics"},{"key":"BF03259913_CR121","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1365-2125.1986.tb02886.x","volume":"22","author":"GM Pacifici","year":"1986","unstructured":"Pacifici GM, Franchi M, Bencini C, Rane A. Valpromide inhibits human epoxide hydrolase. British Journal of Clinical Pharmacology 22: 269\u2013274, 1986","journal-title":"British Journal of Clinical Pharmacology"},{"key":"BF03259913_CR122","first-page":"442","volume":"6","author":"M Paganini","year":"1984","unstructured":"Paganini M, Zaccara G, Campostrini R, Valenza T, Angelastro R, et al. Venous blood ammonia concentrations in adult epileptic patients are increased by treatment with valproic acid. Acta Neurologica (Napoli) 6: 442\u2013446, 1984","journal-title":"Acta Neurologica (Napoli)"},{"key":"BF03259913_CR123","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1212\/WNL.33.10.1374","volume":"33","author":"WD Parker","year":"1983","unstructured":"Parker WD, Haas R, Stumpf DA, Eguren LA. Effects of octanoate on rat brain and liver mitochondria. Neurology 33: 1374\u20131377, 1983","journal-title":"Neurology"},{"key":"BF03259913_CR124","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0140-6736(76)90667-X","volume":"2","author":"JC Partin","year":"1976","unstructured":"Partin JC, Partin JS, Saalfield K, Schubert WK, Jacobs R. Isolation of influenza virus from liver and muscle biopsy specimens from a surviving case of Reye\u2019s syndrome. Lancet 2: 599\u2013602, 1976","journal-title":"Lancet"},{"key":"BF03259913_CR125","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1056\/NEJM197112092852402","volume":"285","author":"JC Partin","year":"1971","unstructured":"Partin JC, Schubert WK, Partin JS. Mitochondrial ultrastructure in Reye\u2019s syndrome (encephalopathy and fatty degeneration of the viscera). New England Journal of Medicine 285: 1339\u20131343, 1971","journal-title":"New England Journal of Medicine"},{"key":"BF03259913_CR126","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1097\/00005072-197509000-00005","volume":"34","author":"JC Partin","year":"1975","unstructured":"Partin JC, Partin JS, Schubert WK, et al. Brain ultrastructure in Reye\u2019s syndrome. Journal of Neuropathology and Experimental Neurology 34: 425\u2013444, 1975","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"BF03259913_CR127","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/hep.1840040421","volume":"4","author":"JS Partin","year":"1984","unstructured":"Partin JS, Daugherty CC, McAdams AJ, Partin JC, Schubert WK. A comparison of liver ultrastructure in salicylate intoxication and Reye\u2019s syndrome. Hepatology 4: 687\u2013690, 1984","journal-title":"Hepatology"},{"key":"BF03259913_CR128","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0140-6736(82)90759-0","volume":"1","author":"JS Partin","year":"1982","unstructured":"Partin JS, Partin JC, Schubert WK, Hammond JG. Serum salicylate concentrations in Reye\u2019s disease \u2014 a study of 130 biopsy proven cases. Lancet 1: 191\u2013193, 1982","journal-title":"Lancet"},{"key":"BF03259913_CR129","first-page":"63","volume":"4","author":"WV Petrykowski","year":"1985","unstructured":"Petrykowski WV, Ketelsen UP, Schmidt-Sommerfield E, Penn D, Sawicka E, et al. Primary systemic carnitine deficiency under successful therapy: clinical, biochemical, ultrahistochemical and renal clearance studies. Clinical Neuropathology 4: 63\u201371, 1985","journal-title":"Clinical Neuropathology"},{"key":"BF03259913_CR130","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1001\/jama.1988.03410050077033","volume":"260","author":"PF Pinsky","year":"1988","unstructured":"Pinsky PF, Hurwitz ES, Schonberger LB, Gunn WJ. Reye\u2019s syndrome and aspirin: evidence for a dose-response effect. Journal of the American Medical Association 260: 657\u2013661, 1988","journal-title":"Journal of the American Medical Association"},{"key":"BF03259913_CR131","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1136\/gut.25.6.673","volume":"25","author":"PR Powell-Jackson","year":"1984","unstructured":"Powell-Jackson PR, Tredger JM, Williams R. Hepatotoxicity to sodium valproate: a review. Gut 25: 673\u2013681, 1984","journal-title":"Gut"},{"key":"BF03259913_CR132","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/0009-8981(76)90060-7","volume":"66","author":"H Przyrembel","year":"1976","unstructured":"Przyrembel H, Wendel U, Becker K. Glutaric aciduria type II: report on a previously undescribed metabolic disorder. Clinica Chimica Acta 66: 227\u2013239, 1976","journal-title":"Clinica Chimica Acta"},{"key":"BF03259913_CR133","first-page":"100","volume":"22","author":"RN Ratnaike","year":"1986","unstructured":"Ratnaike RN, Schapel GJ, Purdie G, Rischbieth RH, Hoffmann S. Hyperammonemia and hepatotoxicity during chronic valproate therapy: enhancement by combination with other anti-opileptic drugs. British Journal of Ciinical Pharmacology 22: 100\u2013103, 1986","journal-title":"British Journal of Ciinical Pharmacology"},{"key":"BF03259913_CR134","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S0022-3476(85)80179-7","volume":"107","author":"RM Rennebohm","year":"1985","unstructured":"Rennebohm RM, Heubi JE, Daugherty CC, Daniels SR. Reye\u2019s syndrome in children receiving salicylate therapy for connective tissue disease. Journal of Pediatrics 107: 877\u2013880, 1985","journal-title":"Journal of Pediatrics"},{"key":"BF03259913_CR135","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/S0140-6736(63)90554-3","volume":"2","author":"RDK Reye","year":"1963","unstructured":"Reye RDK, Morgan G, Baral J. Encephalopathy and fatty degeneration of the viscera: a disease entity in childhood. Lancet 2: 749, 1963","journal-title":"Lancet"},{"key":"BF03259913_CR136","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0022-3476(72)80500-6","volume":"80","author":"DW Reynolds","year":"1972","unstructured":"Reynolds DW, Riley HD, LaFont DS, et al. An outbreak of Reye\u2019s syndrome associated with influenza B. Journal of Pediatrics 80: 429\u2013432, 1972","journal-title":"Journal of Pediatrics"},{"key":"BF03259913_CR137","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1056\/NEJM198811173192003","volume":"319","author":"P Rinaldo","year":"1988","unstructured":"Rinaldo P, O\u2019Shea JJ, Coates PM, Hale DE, Stanley CA, et al. Medium chain acyl-CoA dehydrogenase deficiency: diagnosis by stable-isotope dilution measurement of urinary n-hexanoylglycine and 3-phenylpropionylglycine. New England Journal of Medicine 319: 1308\u20131313, 1988","journal-title":"New England Journal of Medicine"},{"key":"BF03259913_CR138","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1203\/00006450-197704000-00003","volume":"11","author":"BH Robinson","year":"1977","unstructured":"Robinson BH, Gall DG, Cutz E. Deficient activity of hepatic pyruvate dehydrogenase and pyruvate carboxylase in Reye\u2019s syndrome. Pediatric Research 11: 279\u2013281, 1977","journal-title":"Pediatric Research"},{"key":"BF03259913_CR139","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1203\/00006450-197811000-00003","volume":"12","author":"BH Robinson","year":"1978","unstructured":"Robinson BH, Taylor J, Cutz E, Gall DG. Reye\u2019s syndrome: preservation of mitochondrial enzymes in brain and muscle compared with liver. Pediatric Research 12: 1045\u20131047, 1978","journal-title":"Pediatric Research"},{"key":"BF03259913_CR140","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-3476(86)80762-4","volume":"108","author":"CR Roe","year":"1986","unstructured":"Roe CR, Millington DS, Maltby DA, Kinnebrew P. Recognition of medium-chain acyl-CoA dehydrogenase deficiency in asymptomatic siblings of children dying of sudden infant death or Reyes-like syndromes. Journal of Pediatrics 108: 13\u201318, 1986","journal-title":"Journal of Pediatrics"},{"key":"BF03259913_CR141","doi-asserted-by":"crossref","first-page":"759","DOI":"10.3109\/00498258509047438","volume":"15","author":"V Rogiers","year":"1985","unstructured":"Rogiers V, Vandenberghe Y, Vercruysse A. Inhibition of gluconeogenesis by sodium valproate and its metabolites in isolated rat hepatocytes. Xenobiotica 15: 759\u2013765, 1985","journal-title":"Xenobiotica"},{"key":"BF03259913_CR142","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S0022-3476(81)80849-9","volume":"98","author":"CA Romshe","year":"1981","unstructured":"Romshe CA, Hilty MD, McClung HJ, Kerner B, Reiner CB. Amino acid pattern in Reye\u2019s syndrome: comparison with clinical similar entities. Journal of Pediatrics 98: 788, 1981","journal-title":"Journal of Pediatrics"},{"key":"BF03259913_CR143","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.1987.03390010066030","volume":"257","author":"NS Ross","year":"1987","unstructured":"Ross NS, Hoppel CL. Partial muscle carnitine palmitoyl-transferase-A deficiency: rhabdomyolysis associated with transiently decreased muscle carnitine content after ibuprofen therapy. Journal of the American Medical Association 257: 62\u201365, 1987","journal-title":"Journal of the American Medical Association"},{"key":"BF03259913_CR144","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1001\/jama.1988.03410210079041","volume":"260","author":"PC Rowe","year":"1988","unstructured":"Rowe PC, Valle D, Brusilow SW. Inborn errors of metabolism in children with Reye\u2019s syndrome: a changing pattern. Journal of the American Medical Association 260: 3167\u20133170, 1988","journal-title":"Journal of the American Medical Association"},{"key":"BF03259913_CR145","first-page":"295","volume":"17","author":"C Sansaricq","year":"1983","unstructured":"Sansaricq C, Kaufman R, DiMauro S, et al. Mixed form of carnitine deficiency with dicarboxylic aciduria unresponsive to carnitine. Pediatric Research 17: 295, 1983","journal-title":"Pediatric Research"},{"key":"BF03259913_CR146","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/art.1780190205","volume":"19","author":"WH Seaman","year":"1976","unstructured":"Seaman WH, Plotz PH. Effects of aspirin on liver tests in patients with RA or SLE and in normal volunteers. Arthritis and Rheumatism 19: 155\u2013160, 1976","journal-title":"Arthritis and Rheumatism"},{"key":"BF03259913_CR147","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1111\/j.2042-7158.1969.tb08202.x","volume":"21","author":"AE Senior","year":"1969","unstructured":"Senior AE, Sherratt HSA. A comparison of the effects on blood glucose and ketone body levels and of the toxicities of pent-4-enoic acid and four simple fatty acids. Journal of Pharmacy and Pharmacology 21: 85\u201392, 1969","journal-title":"Journal of Pharmacy and Pharmacology"},{"key":"BF03259913_CR148","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/BF03047375","volume":"7","author":"HSA Sherratt","year":"1984","unstructured":"Sherratt HSA, Veitch RK. Animal models for dicarboxylic aciduria. Journal of Inherited Metabolic Disease 7: 52\u201356, 1984","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"BF03259913_CR149","first-page":"370","volume-title":"The metabolic basis of inherited disease","author":"VE Shih","year":"1972","unstructured":"Shih VE, Efron ML. Urea cycle disorders. In Stanbury et al. (Eds) The metabolic basis of inherited disease, pp. 370\u2013392, McGraw-Hill Book Co., Inc., New York, 1972"},{"key":"BF03259913_CR150","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/0009-8981(78)90289-9","volume":"88","author":"VE Shih","year":"1978","unstructured":"Shih VE, Tanaka K. Plasmas and urine amino acid changes in rats treated with hypoglycin. Clinica Chimica Acta 88: 539, 1978","journal-title":"Clinica Chimica Acta"},{"key":"BF03259913_CR151","first-page":"829","volume":"9","author":"F Sinatra","year":"1975","unstructured":"Sinatra F, Yoshida T, Applebaum M, Mason W, Hoogenraad NJ, et al. Abnormalities of carbamyl phosphate synthetase and ornithine transcarbamylase in liver of patients with Reye\u2019s syndrome. Pediatric Research 9: 829\u2013833, 1975","journal-title":"Pediatric Research"},{"key":"BF03259913_CR152","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1212\/WNL.33.1.29","volume":"33","author":"AE Slonim","year":"1983","unstructured":"Slonim AE, Bourn PR, Mrak RE, Najjar J, Richardson D, et al. Nonketotic hypoglycemia: an early indicator of systemic carnitine deficiency. Neurology 33: 29\u201333, 1983","journal-title":"Neurology"},{"key":"BF03259913_CR153","first-page":"53","volume-title":"The salicylates \u2014 a critical bibliographic review","author":"MJH Smith","year":"1966","unstructured":"Smith MJH, Smith PK. The salicylates \u2014 a critical bibliographic review, pp. 53\u201378, John Wiley and Sons, New York, 1966"},{"key":"BF03259913_CR154","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1203\/00006450-198507000-00006","volume":"19","author":"CA Stanley","year":"1985","unstructured":"Stanley CA. Long-chain acyl coenzyme A dehydrogenase deficiency: an inherited cause of nonketotic hypoglycemia. Pediatric Research 19: 666\u2013671, 1985","journal-title":"Pediatric Research"},{"key":"BF03259913_CR155","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1203\/00006450-198311000-00008","volume":"17","author":"CA Stanley","year":"1983","unstructured":"Stanley CA, Hale DE, Coates PM, Hall CJ, Corbey BE. Medium chain acyl CoA dehydrogenase deficiency in children in nonketotic hypoglycemia and low carnitine levels. Pediatric Research 17: 877\u2013884, 1983.","journal-title":"Pediatric Research"},{"key":"BF03259913_CR156","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1203\/00006450-198304000-00014","volume":"17","author":"CA Stanley","year":"1983","unstructured":"Stanley CA, Hale DE, Whiteman DEH, et al. Systemic carnitine deficiency in isovaleric acidemia (IVA). Pediatric Research 17: 296, 1983","journal-title":"Pediatric Research"},{"key":"BF03259913_CR157","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(83)91629-X","volume":"1","author":"RM Starko","year":"1983","unstructured":"Starko RM, Mullick FG. Hepatic and cerebral pathology findings in children with fatal salicylate intoxication: further evidence for a causal relation between salicylate and Reyes syndrome. Lancet 1: 326\u2013329, 1983","journal-title":"Lancet"},{"key":"BF03259913_CR158","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1542\/peds.66.6.859","volume":"66","author":"RM Starko","year":"1980","unstructured":"Starko RM, Ray G, Dominguez LB, Stromberg WL, Woodall DF. Reye\u2019s syndrome and salicylate use. Pediatrics 66: 859\u2013864, 1980","journal-title":"Pediatrics"},{"key":"BF03259913_CR159","first-page":"117","volume-title":"Current neurology, Vol. 2","author":"DA Stumpf","year":"1979","unstructured":"Stumpf DA. Mitochondrial multisystem disorders: clinical, biochemical and morphological features. In Tyler & Dawson (Eds) Current neurology, Vol. 2, pp. 117\u2013149, Houghton-Mifflin Professional, Boston, 1979"},{"key":"BF03259913_CR160","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1001\/jama.1979.03300110045025","volume":"242","author":"NM Sussman","year":"1979","unstructured":"Sussman NM, McLain LW. A direct hepatotoxic effect of valproic acid. Journal of the American Medical Association 242: 1173\u20131174, 1979","journal-title":"Journal of the American Medical Association"},{"key":"BF03259913_CR161","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1016\/S0022-3476(80)80629-9","volume":"96","author":"L Sweetman","year":"1980","unstructured":"Sweetman L, Nyhan WJ, Trauner DA, Merritt A, Singh M. Glutaric aciduria type II. Journal of Pediatrics 96: 1020\u20131026, 1980","journal-title":"Journal of Pediatrics"},{"key":"BF03259913_CR162","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1056\/NEJM197608262950901","volume":"295","author":"K Tanaka","year":"1976","unstructured":"Tanaka K, Kean EA, Johnson B. Jamaican vomiting sickness: biochemical investigation of two cases. New England Journal of Medicine 295: 461\u2013467, 1976a","journal-title":"New England Journal of Medicine"},{"key":"BF03259913_CR163","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0009-8981(76)90478-2","volume":"69","author":"K Tanaka","year":"1976","unstructured":"Tanaka K, Ramsdell HS, Baretz BH, Keefe MB, Kean EA, Johnson B. Identification of ethylmalonic acid in urine of two patients with the vomiting sickness of Jamaica. Clinica Chimica Acta 69: 105, 1976b","journal-title":"Clinica Chimica Acta"},{"key":"BF03259913_CR164","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.175.4017.69","volume":"175","author":"K Tanaka","year":"1972","unstructured":"Tanaka K, Shih V. Isovaleric and alpha methylbutyric acidemias induced by hypoglycin A: mechanism of Jamaican vomiting sickness. Science 175: 69\u201371, 1972","journal-title":"Science"},{"key":"BF03259913_CR165","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1542\/peds.79.3.382","volume":"79","author":"B Taubman","year":"1987","unstructured":"Taubman B, Hale DE, Kelley FI. Familial Reyes-like syndrome: a presentation of medium-chain acyl-coenzyme A dehydrogenase deficiency. Pediatrics 79: 382\u2013385, 1987","journal-title":"Pediatrics"},{"key":"BF03259913_CR166","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archpedi.1976.02120040019004","volume":"130","author":"MM Thaler","year":"1976","unstructured":"Thaler MM. Metabolic mechanisms in Reye\u2019s syndrome. American Journal of Diseases of Children 130: 241\u2013243, 1976","journal-title":"American Journal of Diseases of Children"},{"key":"BF03259913_CR167","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/0024-3205(85)90367-4","volume":"36","author":"JH Thurston","year":"1985","unstructured":"Thurston JH, Carroll JE, Hauhart RE, Schiro JA. A single therapeutic dose of valproate affects liver carbohydrate, fat, adenylate, amino acid, coenzyme A, and carnitine metabolism in infant mice: possible clinical significance. Life Sciences 36: 1643\u20131651, 1985","journal-title":"Life Sciences"},{"key":"BF03259913_CR168","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0022-3476(85)80619-3","volume":"107","author":"JH Tonsgard","year":"1985","unstructured":"Tonsgard JH. Urinary dicarboxylic acids in Reye\u2019s syndrome. Journal of Pediatrics 107: 79\u201384, 1985","journal-title":"Journal of Pediatrics"},{"key":"BF03259913_CR169","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S0022-3476(86)80114-7","volume":"109","author":"JH Tonsgard","year":"1986","unstructured":"Tonsgard JH. Serum dicarboxylic acids in patients with Reye\u2019s syndrome. Journal of Pediatrics 109 440\u2013445, 1986","journal-title":"Journal of Pediatrics"},{"key":"BF03259913_CR170","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1172\/JCI112039","volume":"76","author":"JH Tonsgard","year":"1985","unstructured":"Tonsgard JH, Getz GS. Effect of Reye\u2019s syndrome serum on isolated chichilla liver mitochondria. Journal of Clinical Investigation 76: 816\u2013825, 1985","journal-title":"Journal of Clinical Investigation"},{"key":"BF03259913_CR171","first-page":"206","volume":"141","author":"DA Trauner","year":"1984","unstructured":"Trauner DA. Reye\u2019s syndrome. Western Journal of Medicine 141: 206\u2013209, 1984","journal-title":"Western Journal of Medicine"},{"key":"BF03259913_CR172","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1203\/00006450-198211000-00010","volume":"16","author":"DA Trauner","year":"1982","unstructured":"Trauner DA. Pathologic changes in a rabbit model of Reye\u2019s syndrome. Pediatric Research 16: 950\u2013953, 1982","journal-title":"Pediatric Research"},{"key":"BF03259913_CR173","first-page":"1097","volume":"15","author":"DA Trauner","year":"1981","unstructured":"Trauner DA, Adams H. Intracranial pressure elevations during octanoate infusion in rabbits: an experimental model of Reye\u2019s syndrome. Pediatric Research 15: 1097\u20131099, 1981","journal-title":"Pediatric Research"},{"key":"BF03259913_CR174","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1212\/WNL.25.3.296","volume":"25","author":"DA Trauner","year":"1975","unstructured":"Trauner DA, Nyhan WL, Sweetman L. Short-chain organic acidemia and Reye\u2019s syndrome. Neurology 25: 269\u2013298, 1975","journal-title":"Neurology"},{"key":"BF03259913_CR175","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/ana.410020310","volume":"2","author":"DA Trauner","year":"1977","unstructured":"Trauner DA, Sweetman L, Holm J, Kulovich S, Nyhan WS. Biochemical correlates of illness and recovery in Reye\u2019s syndrome. Annals of Neurology 2: 238\u2013241, 1977","journal-title":"Annals of Neurology"},{"key":"BF03259913_CR176","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1056\/NEJM198811173192006","volume":"319","author":"WR Treem","year":"1988","unstructured":"Treem WR, Stanley CA, Finegold DN, Hale DE, Coates PM. Primary carnitine deficiency due to a failure of carnitine transport in the kidney, muscle and fibroblasts. New England Journal of Medicine 319: 1331\u20131336, 1988","journal-title":"New England Journal of Medicine"},{"key":"BF03259913_CR177","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1056\/NEJM198411083111906","volume":"311","author":"DM Turnbull","year":"1984","unstructured":"Turnbull DM, Bartlett K, Stevens DL, Alberti KGMM, Gibson GJ, et al. Short chain acyl-CoA dehydrogenase deficiency associated with a lipid-storage myopathy and secondary carnitine deficiency. New England Journal of Medicine 311: 1232\u20131236, 1984","journal-title":"New England Journal of Medicine"},{"key":"BF03259913_CR178","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/0006-2952(83)90054-0","volume":"32","author":"DM Turnbull","year":"1983","unstructured":"Turnbull DM, Bone AJ, Bartlett K, Koundakjian PP, Sherratt HS. The effects of valproate on intermediary metabolism in isolated rat hepatocytes and intact rats. Biochemical Pharmacology 32: 1887\u20131892, 1983","journal-title":"Biochemical Pharmacology"},{"key":"BF03259913_CR179","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/jnnp.49.4.405","volume":"49","author":"DM Turnbull","year":"1986","unstructured":"Turnbull DM, Dick DJ, Wilson L, Sherratt HSA. Valproate causes metabolic disturbance in normal man. Journal of Neurology, Neurosurgery and Psychiatry 49: 405\u2013410, 1986","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"BF03259913_CR180","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1016\/0006-2952(85)90409-5","volume":"34","author":"C Branden Van den","year":"1985","unstructured":"Van den Branden C, Roels F. Peroxisomal \u03b2-oxidation and sodium valproate. Biochemical Pharmacology 34: 2147\u20132149, 1985","journal-title":"Biochemical Pharmacology"},{"issue":"1","key":"BF03259913_CR181","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/BF01812855","volume":"10","author":"C Vianey-Liaud","year":"1987","unstructured":"Vianey-Liaud C, Divry P, Gregersen N, Matthieu M. The inborn errors of mitochondrial fatty acid oxidation. Journal of Inherited Metabolic Disease 10 (Suppl. 1): 159\u2013198, 1987","journal-title":"Journal of Inherited Metabolic Disease"},{"key":"BF03259913_CR182","doi-asserted-by":"crossref","first-page":"9809","DOI":"10.1016\/S0021-9258(19)68697-7","volume":"256","author":"A Wenz","year":"1981","unstructured":"Wenz A, Thorpe C, Ghisla S. Inactivation of general acyl-CoA dehydrogenase from pig kidney by a metabolite of hypoglycin A. Journal of Biological Chemistry 256: 9809\u20139812, 1981","journal-title":"Journal of Biological Chemistry"},{"key":"BF03259913_CR183","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1001\/archpedi.1987.04460060076039","volume":"141","author":"SC Winter","year":"1987","unstructured":"Winter SC, Szabo-Aczel S, Curry CJR, Hutchinson HT, Hogue R, et al. Plasma carnitine deficiency: clinical observations in 51 pediatric patients. American Journal of Diseases of Children 141: 660\u2013665, 1987","journal-title":"American Journal of Diseases of Children"},{"key":"BF03259913_CR184","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1212\/WNL.28.9.961","volume":"28","author":"LJ Willmore","year":"1978","unstructured":"Willmore LJ, Wilden BJ, Bruni J, Villarreal HJ. Effect of valproic acid on hepatic function. Neurology 28: 961\u2013964, 1978","journal-title":"Neurology"},{"key":"BF03259913_CR185","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/BF00765158","volume":"8","author":"L Wojtczak","year":"1976","unstructured":"Wojtczak L. Review effect of long-chain fatty acids and acyl-CoA on mitochondrial permeability, transport, and energy-coupling processes. Journal of Bioenergetics and Biomembranes 8: 293\u2013311, 1976","journal-title":"Journal of Bioenergetics and Biomembranes"},{"key":"BF03259913_CR186","doi-asserted-by":"crossref","first-page":"275","DOI":"10.3949\/ccjm.50.3.275","volume":"50","author":"E Wyllie","year":"1983","unstructured":"Wyllie E, Wyllie R, Rothner AD, Erenberg G, Cruse RP. Valproate-induced hyperammonemia in asymptomatic children. Cleveland Clinic Quarterly 50: 275\u2013277, 1983","journal-title":"Cleveland Clinic Quarterly"},{"key":"BF03259913_CR187","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1128\/IAI.47.1.329-331.1985","volume":"47","author":"MC Yoder","year":"1985","unstructured":"Yoder MC, Egler JM, Yudkoff M, Chatteng Douglas SD, Polin RA. Metabolic and mitochondrial morphological changes that mimic Reye\u2019s syndrome after endotoxin administration to rats. Infection and Immunity 47: 329\u2013331, 1985","journal-title":"Infection and Immunity"},{"key":"BF03259913_CR188","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1126\/science.6857275","volume":"221","author":"KS You","year":"1983","unstructured":"You KS. Salicylate and mitochondrial injury in Reye\u2019s syndrome. Science 221: 163\u2013165, 1983","journal-title":"Science"},{"key":"BF03259913_CR189","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1002\/ana.410070423","volume":"7","author":"RK Young","year":"1980","unstructured":"Young RK, Bergman I, Gand DL, et al. Fatal Reyes-like syndrome associated with valproic acid. Annals of Neurology 7: 389, 1980","journal-title":"Annals of Neurology"},{"key":"BF03259913_CR190","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1600-0404.1983.tb04832.x","volume":"68","author":"G Zaccara","year":"1983","unstructured":"Zaccara G, Boncinelli L, Paganini M, Campostrini R, Arnetoli G, et al. Treatment of epileptic patients with valproic acid does not modify plasma and urine short-chain fatty acids. Acta Neurologica Scandinavica 68: 241\u2013247, 1983","journal-title":"Acta Neurologica Scandinavica"},{"key":"BF03259913_CR191","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1097\/00007691-198703000-00007","volume":"9","author":"G Zaccara","year":"1987","unstructured":"Zaccara G, Campostrini R, Paganini M, et al. Long-term treatment with sodium valproate: monitoring of venous ammonia concentrations and adverse effects. Therapeutic Drug Monitoring 9: 34\u201340, 1987","journal-title":"Therapeutic Drug Monitoring"},{"key":"BF03259913_CR192","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/hep.1840020520","volume":"2","author":"ES Zafrani","year":"1982","unstructured":"Zafrani ES, Berthelot P. Sodium valproate in the induction of unusual hepatotoxicity. Hepatology 2: 648\u2013649, 1982","journal-title":"Hepatology"},{"key":"BF03259913_CR193","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1001\/archinte.1981.00340030065013","volume":"141","author":"HJ Zimmerman","year":"1981","unstructured":"Zimmerman HJ. Effects of aspirin and acetaminophen on the liver. Archives of Internal Medicine 141: 333\u2013342, 1981","journal-title":"Archives of Internal Medicine"},{"key":"BF03259913_CR194","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/hep.1840020513","volume":"2","author":"HJ Zimmerman","year":"1982","unstructured":"Zimmerman HJ, Ishak KG. Valproate-induced hepatic injury: analyses of 23 fatal cases. Hepatology 2: 591\u2013597, 1982","journal-title":"Hepatology"}],"container-title":["Medical Toxicology and Adverse Drug Experience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259913.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03259913\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03259913","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T00:28:35Z","timestamp":1745368115000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03259913"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1989,8]]},"references-count":194,"journal-issue":{"issue":"4","published-print":{"date-parts":[[1989,8]]}},"alternative-id":["BF03259913"],"URL":"https:\/\/doi.org\/10.1007\/bf03259913","relation":{},"ISSN":["0113-5244","1179-1942"],"issn-type":[{"value":"0113-5244","type":"print"},{"value":"1179-1942","type":"electronic"}],"subject":[],"published":{"date-parts":[[1989,8]]}}}